Microbiology Testing Market Research Report - Global Forecast till 2027

Microbiology Testing Market Research Report: Information by Product Type (Instruments, Chemicals & Reagents, Consumables & Accessories and others), Application (Gastrointestinal Infections, Respiratory Infections, Urinary Tract Infections, Sexually Transmitted Infections and others), End User (Hospital Associate Laboratory, Independent Laboratory and Academic and Research Institutes) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027

ID: MRFR/LS/0226-CR | June 2017 | Region: Global | 188 pages

Please note that the assessment period of report has been updated from 2016-2023 to 2020-2027. Cordially fill the sample form for updated data.

Overview


The Global Microbiology Testing Market is expected to register 10.4% CAGR and is anticipated to reach USD 5409.1 6 Million by 2023. Microbiology testing services help to lower the potential damage risk by microbes and to ensure that the microbiology quality of the products is maintained. The microbial testing technique includes chemical, biological, biochemical, or molecular methods to quantify and identify microbes.


Technological advancements, rising cases of infectious diseases, surveillance programs for disease control, increasing stringency of standards, weakness of traditional laboratory techniques are the major drivers propelling market growth. However, erroneous results and high cost of reagents and instruments may constrain the growth of the market.


Market Dynamics


Technological advancements are expected to drive the growth of the market. For instance, according to the data published by the National Centre for Health Statistics in 2017, there were around 9,272 cases of tuberculosis infectious disease. Additionally, rising cases of infectious diseases, surveillance programs for disease control, increasing stringency of standards, weakness of traditional laboratory techniques are likely to support market growth. On the other hand, erroneous results and high cost of reagents and instruments are anticipated to hamper the market growth.


Global Microbiology Testing Market Size, by Product Type, 2016 & 2023 (USD Million)  Microbiology Testing Market


 Source: MRFR Analysis


Segmentation


The global market has been segmented into product type, application, and end user. 


Based on type, the global market has been segmented into instruments, chemicals & reagents, consumables & accessories, and others. The instruments segment accounted for a market value of USD 954.9 million in 2016.


Based on application, the global market has been segmented into gastrointestinal infections, respiratory infections, urinary tract infections, sexually transmitted infections, and others.


Based on end user, the global market has been segmented into hospital associate laboratory, independent laboratory, and academic and research institutes.


Key Players


The prominent players in the global microbiology testing market are, Beckman Coulter, Inc. (a subsidiary of Danaher Corp), BioMérieux SA, Thermo Fisher Scientific Inc., Cepheid (a subsidiary of Danaher), and F. Hoffmann-La Roche Ltd.


Some of the key strategies followed by the players operating in the global microbiology testing market were innovation, product development, acquisition, and expansion.


Asia-Pacific Microbiology Testing Market Share, by Country, 2016 (%)  Microbiology Testing Market


Source: MRFR Analysis


Regional Analysis


The global microbiology testing market, based on region, is segmented into North Americas, Europe, Asia-Pacific, and the Middle East & Africa.


North America is estimated to dominate the global microbiology testing market during the forecast period. This can be attributed to the rapid adoption of advanced products and techniques. The European market for microbiology testing is expected to be the second-largest during the forecast period. Increasing innovation and changing laboratory practices is expected to boost the growth of the market in this region.


Asia-Pacific is estimated to be the fastest-growing market due to increasing funding for R&D, developing healthcare infrastructure, growing awareness about microbiology testing, government initiatives to improve public health, and growing investments by major players. Moreover, in the region, South Korea accounted for a market share of 9.2% in 2016.


The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities, lack of knowledge of new microbiology testing techniques, less funding R&D, and limited availability to equipment.


Key Updates



  • In April 2017, Alere Inc. and Abbott announced agreement for Abbott's acquisition of Alere. The transaction is expected to close by the end of the third quarter of 2017.



  • In August 2016, Beckman Coulter, Inc., an Italian multinational biotechnology company, and DiaSorin S.p.A. formed a partnership to provide LIAISON XL Hepatitis A, B, C, and HIV products in the US market.



  • In April 2017, Hoffmann-La Roche AG received 510(k) clearance from the US FDA for its CINtec Histology test. This test is the only clinically validated p16 biomarker test. The CINtec Histology test will help physicians make informed decisions as to the best course of care for patients with high-grade pre-cancerous cervical disease.




  • Global Microbiology Testing Market, by Product Type



  • Instruments

  • Chemicals & Reagents

  • Consumables & Accessories

  • Others


Global Microbiology Testing Market, by Application



  • Gastrointestinal Infections

  • Respiratory Infections

  • Urinary tract Infections

  • Sexually Transmitted Infections

  • Others


Global Microbiology Testing Market, by End User



  • Hospital Associate Laboratory

  • Independent Laboratory

  • Academic and Research Institutes


Global Microbiology Testing Market, by Region



  • North America

    • US

    • Canada





  • Europe

    • Germany

      • UK

      • France

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • UAE

    • Saudi Arabia

    • Egypt

    • Rest of Middle East & Africa




Available Additional Customizations



  • Additional Companies

    • Bruker Corporation

    • Bio-Rad Laboratories Inc.

    • Bruker Corporation

    • Gen-Probe, Inc.

    • Siemens Healthcare Diagnostics, Inc.

    • Sysmex Corporation





  •  Regional Segmentation in the Americas


Intended Audience



  • Medical device manufacturers and distributors

  • Government research organizations

  • Hospitals and clinics

  • Regulatory agencies

  • Pharmaceutical companies



Frequently Asked Questions (FAQ) :


Microbiology Testing Market is projected to grow at an 10.4% CAGR between 2020-2027.

Microbiology Testing Market is predicted to touch USD 5409.16 million by 2023.

North America is predicted to have the highest share in the Microbiology Testing Market.

Top players profiled in the Microbiology Testing Market include F. Hoffmann-La Roche Ltd, Cepheid (a subsidiary of Danaher), Thermo Fisher Scientific Inc., BioMérieux SA, and Beckman Coulter, Inc. (a subsidiary of Danaher Corp).

Various strategies incorporated by industry players to maintain dominance in the Microbiology Testing Market include expansion, product development, innovation, and acquisition.